Sirtuins: Common Targets in Aging and in Neurodegeneration

被引:0
|
作者
de Oliveira, Rita Machado [1 ]
Pais, Teresa F. [1 ]
Outeiro, Tiago Fleming [1 ,2 ]
机构
[1] Inst Mol Med, Cell & Mol Neurosci Unit, P-1649028 Lisbon, Portugal
[2] Fac Med Lisbon, Inst Fisiol, P-1649028 Lisbon, Portugal
关键词
Neurodegeneration; sirtuins; Parkinson's disease; Alzheimer's disease; therapeutic targets; aging; FOXO TRANSCRIPTION FACTORS; SMALL-MOLECULE ACTIVATORS; OXIDATIVE STRESS; SACCHAROMYCES-CEREVISIAE; CALORIE RESTRICTION; HISTONE DEACETYLASE; ALZHEIMERS-DISEASE; SIRT1; ACTIVATION; ALPHA-SYNUCLEIN; MITOCHONDRIAL DYSFUNCTION;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Aging has been a subject of interest since primordial times. More recently, it became clear that aging is the major known risk factor for several neurodegenerative disorders, such as Alzheimer's disease, Parkinson's disease and Huntington's disease. A major focus in the field of aging is to examine whether the genetic regulators of lifespan also regulate the trigger and/or progression of age-related disorders. Sirtuins, which belong to the Sir2 family of NAD(+)-dependent deacetylases, are known to regulate longevity in yeast, worms, and flies. In mammals, there are seven homologs of the yeast Sir2, Sirt1-7. Therefore, the challenge now is to unravel howthe seven mammalian Sir2 proteins communicate to regulate the cross talk between aging and the onset and progression of age-related disorders. Here, we review how sirtuins contribute for aging and, in particular, for neurodegeneration and how they are becoming attractive targets for therapeutic intervention.
引用
收藏
页码:1270 / 1280
页数:11
相关论文
共 50 条
  • [21] Retinal Aging and Sirtuins
    Ozawa, Yoko
    Kubota, Shunsuke
    Narimatsu, Toshio
    Yuki, Kenya
    Koto, Takashi
    Sasaki, Mariko
    Tsubota, Kazuo
    OPHTHALMIC RESEARCH, 2010, 44 (03) : 199 - 203
  • [22] SIRTUINS AS THERAPEUTIC TARGETS FOR NEUROBLASTOMA
    Hernandez, Fiorela
    De Angulo, Guillermo
    Vanni, Steven
    Graham, Regina
    PEDIATRIC BLOOD & CANCER, 2013, 60 : S63 - S64
  • [23] Sirtuins as therapeutic targets in diabetes
    Kielbowski, Kajetan
    Bratborska, Aleksandra Wiktoria
    Bakinowska, Estera
    Pawlik, Andrzej
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2025, 29 (03) : 117 - 135
  • [24] Sirtuins: Multifaceted Drug Targets
    Chakrabarty, S. P.
    Balaram, H.
    Chandrasekaran, S.
    CURRENT MOLECULAR MEDICINE, 2011, 11 (09) : 709 - 718
  • [25] Schistosome sirtuins as drug targets
    Lancelot, Julien
    Cabezas-Cruz, Alejandro
    Caby, Stephanie
    Marek, Martin
    Schultz, Johan
    Romier, Christophe
    Sippl, Wolfgang
    Jung, Manfred
    Pierce, Raymond J.
    FUTURE MEDICINAL CHEMISTRY, 2015, 7 (06) : 765 - 782
  • [26] Sirtuins as therapeutic targets of ALS
    Giulio Maria Pasinetti
    Amanda E Bilski
    Wei Zhao
    Cell Research, 2013, 23 : 1073 - 1074
  • [27] Metabolism, neurodegeneration and epigenetics: emerging role of Sirtuins
    Silberman, Dafne M.
    NEURAL REGENERATION RESEARCH, 2018, 13 (03) : 417 - 418
  • [28] Sirtuins as therapeutic targets of ALS
    Pasinetti, Giulio Maria
    Bilski, Amanda E.
    Zhao, Wei
    CELL RESEARCH, 2013, 23 (09) : 1073 - 1074
  • [29] Metabolism, neurodegeneration and epigenetics: emerging role of Sirtuins
    Dafne M.Silberman
    NeuralRegenerationResearch, 2018, 13 (03) : 417 - 418
  • [30] SIRTUINS: A NOVEL LINK BETWEEN NEUROIFLAMMATION AND NEURODEGENERATION
    Pais, T. F.
    Fleming, Miller L.
    Marques, O.
    Guerreiro, P.
    Oliveira, R.
    Outeiro, Fleming T.
    GLIA, 2011, 59 : S136 - S136